<script type="text/javascript" src="https://pppbr.com/bnr.php?section=Footer46860&pub=543549&format=728x90&ga=g&bg=1"></script>
<noscript><a href="https://yllix.com/publishers/543549" target="_blank"><img src="//ylx-aff.advertica-cdn.com/pub/728x90.png" style="border:none;margin:0;padding:0;vertical-align:baseline;" alt="ylliX - Online Advertising Network" /></a></noscript>
Shares of Novavax Inc (NASDAQ: NVAX) opened about 25% down this morning on a report that the biotech firm continues to struggle in manufacturing its COVID-19 vaccine at scale. Novavax is yet to secure emergency use authorisation Earlier this year, Novavax said its vaccine showed 93% efficacy against the Coronavirus.
...read full article on Invezz
